ArticleHemaSphere2025

Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study.

Mariana Bastos-Oreiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.